MQ 2022 ANNUAL REPORT
LOOKING BACK TO SHAPE THE FUTURE
MQ: Transforming Mental Health 2022 ANNUAL REPORT
Trustees report and financial statements for the year ended December 2022
1
MQ 2022 ANNUAL REPORT
Contents
19 MQ Mental Health Research’s charitable objects
3 Administrative details 4 Annual Report 2022 – introduction 6 Letter from the Chairman 7 Statistics 8 Pathway to sustainability 10 The MQ Science Council 11 Gone too soon 14 Understanding COVID-induced brain fog 16 Financial Review and Strategic Report 16 Summary 16 Income 16 Expenditure 16 Reserve policy 17 Funds 17 Going concern 17 Risk management 18 Corporate Structure and Governance
19 Safeguarding 19 Board and management roles 20 Trustees’ responsibilities in relations to the financial statements 20 Disclosure of the information to Auditor 20 Remuneration policy 21 Fundraising 21 Board composition 21 Board expenses 21 Board meetings 21 Auditor 26 Accounts
MQ 2022 ANNUAL REPORT
Company number 07406055
Charity number 1139916 SC046075
Registered office 6 Honduras Street London EC1Y OTH
Country of registration England & Wales
Country of incorporation United Kingdom
Solicitors
Womble Bond Dickinson 4 More London Riverside London SE1 2AU
Auditors
Moore Kingston Smith LLP 9 Appold Street London EC2A 2AP
Trustees
Trustees, who are also Directors under company law, who served during the year and up to the date of this report were as follows:
Dr Shahzad Malik (Chair) Mr John A Herrmann
Professor Emily Holmes (resigned 19th April 2022) Mr Michael J Horvitz
Professor Peter Jones
Ms Helen Munn OBE Professor Rory O’Connor
Mr James Palmer (Appointed 16th of January 2023)
Mr Chris Parsons
Professor Irene Tracey CBE (resigned 31st December 2022) Ms Sarah Woolnough
Key management
Mr Lea Milligan, CEO
Mr Jey Balakrishnar, Director of Finance & Operations Ms Emily Wheeler, Head of Development Ms Bryony Doughty, Head of Marketing
Mental Health Sciences Council
Chair: Professor Peter Jones Professor Jehannine Austin Professor Hilary Blumberg Professor Kamaldeep Bhui CBE Sir Philip Campbell Professor Lai Fong Chan Dr Dixon Chibanda Professor Helen L. Fisher Professor Stephani Hatch Cynthia Joyce Professor Karoline Kuchenbaecker Professor Andrew McIntosh Dr Helen Munn OBE Professor Rory O’Connor Professor Henriette Raventos Dr Jessica Schleider Professor Daisy Singla Professor Irene Tracey CBE Professor Carol Worthman
For more information about MQ’s Science Council please see page 10.
Bankers
Santander Lloyds Bank Bootle 74-78 Church Road Merseyside Hove L30 4GB BN3 2EE
3
MQ 2022 ANNUAL REPORT
Annual Report 2022: Introduction
~~By Juliette Burton MQ Staf~~
The only constant in life is change. Entering a new year with a new job with MQ as a copywriter was a big change for me and one I’m already viewing in a new light.
A big part of my new role at MQ is to make mental health research more accessible to a wider audience. Sharing the lived experience of mental illness with the widest possible audience is at the heart of Who I Am.
As well as copywriter for MQ, I am comedian, writer and public speaker. For over a decade, I have written about and spoken about my mental health experiences. This path was natural to me. I’d found over the years that, when I told people about my mental illnesses and the dark places they have taken me, laughter was a way of finding the light. Laughter breaks down barriers and increases understanding. If we’re laughing together, we feel less alone. And I do not want anyone to feel as alone as I have.
For years I’ve used creativity and comedy to find light in the darkness of my experiences.
My latest show ‘No Brainer’ is all about neuroscience and what I learned when my brain ‘broke’. After yet further, deeper challenges to my mental health in recent years, I needed to understand why my mind works with my body the way it does. I realised, even after all I’ve learned so far, there was still so much more to discover. And so, I did a deep dive into trying to understand everything I could about my brain. I read books, I consumed content and used what I learned for my show. However, one thing remained clear to me, we don’t yet know enough about mental illness.
Communicating with humour means I can communicate complicated ideas in a palatable way. I can put people at ease. Most of all, I can change the narrative. Too frequently my mental health history, once disclosed, was met with fear, dismissal, or pity. I am not someone to fear, to ignore or to feel sorry for. I am so much more than my mental illnesses, yet I am who I am because of, and in spite of, them.
I was sectioned under the mental health act when I was 17. I’ve been an inpatient for mental illnesses 5 times. I’ve been diagnosed with 15 different mental illnesses. I’ve been in therapy, both private and through the NHS, for over 20 years. I’m what psychiatrists call “a bit much.”
In my disability rights and activism work, there is a phrase I’ve come across to describe the experience of those with physical disabilities: ‘My condition is my medical condition. My disability is how society treats me.’ I live with my mental health conditions but it’s how society treats me unequally that disables me.
4
MQ 2022 ANNUAL REPORT
Comedy is a way to change a narrative of inequality as quickly as possible. I’ve found making someone laugh can be the fastest way to change their perspective, to change their mind about someone or something. If you are laughing with me then you can learn from me too, sometimes without realising. If comedy is a way to change the narrative, then research is the way to make progress.
Making research accessible is key to wider societal progress. Education without accessibility keeps knowledge exclusively for the knowledgeable. Making information not only available but understandable and engaging to as many people as possible helps inform, educate and entertain. Knowledge is power, so making knowledge accessible is empowering.
Making knowledge available to the widest possible audience is what I long to do. Hence why I applied to work for MQ Mental Health Research.
If we’re laughing together, we feel less alone. And I do not want anyone to feel as alone as I have.
Taking big steps forward and challenging the status quo is at the core of how I live. And it was this approach to research that attracted me to MQ. Mental health treatment, prevention and understanding needs to improve. MQ is working with researchers to improve these areas in ways that could affect the medical landscape profoundly in years to come.
For years I’ve been longing for, seeking and attempting to contribute to change; real, systemic change backed by research, not just hyperbole, rhetoric or awareness-raising. Awareness is important, has been important, but it hasn’t moved us as a society forward as fast as we need to so that we can respond to the deepening mental health crisis we all face. Awareness, in my experience, has led to saturation of surface-level knowledge, without depth of repair or strengthening growth. Research is the foundation upon which change can happen. Whether it’s a change to the law, a change to medical practice or other areas, without research to back it up, calls for change will be all too easily dismissed, as they have been in the past.
In the short time I’ve been with MQ so far, I’ve already learned so much more than just logins, colleagues’ names and how to upload HR documents to the server. As someone hungry for knowledge and to translate this knowledge to others, this wealth of exploration excites me greatly. From hypermobility linking to mental illness to ADHD diagnostic criteria to calls for early intervention change and much more; every time I learn about a new research paper, a researcher’s journey or a new call for legislation reform, I light up. Finally, after what feels like a
lifetime of frustration and lack of actual, sustainable change and positive action, I’ve found not only a new job and a new team. I’ve found optimism.
For me, the opposite of depression isn’t happiness. The opposite of depression is purpose. My purpose is to inform, educate and entertain the widest possible audience and contribute to progress. MQ exists for this very purpose too.
My mental health experiences gave me passion for change. Comedy gave me a voice. MQ is now giving me hope for a better future.
5
MQ 2022 ANNUAL REPORT
Letter from the Chairman
The last year has brought a fresh set of new challenges to bear on the mental health of the nation and the world; but thanks to a passionate team of staff, generous donors, and supporters, I am delighted to report that MQ has funded and delivered more worldclass research than ever before. It is this combination of scientific entrepreneurship and passion that drives our thinking and fuels our ambition to transform the landscape of mental health.
MQ has long been a champion of diversity within mental health science; from convening the sector and fostering collaborations between different disciplines; to championing researchers in low-and middleincome countries; to raising the voices of people with lived experience and ensuring research is coproduced. However, 2022 has been a particularly stand-out year. We have doubled the size of our Science Council, ensuring that the experts who set the course for our scientific focus are diverse not just in their area of expertise, but by geography, race and life-experience. You can read more about the Science Council and its newest members on page 10.
In May, we were proud to co-host the MQ Mental Health Research, McPin Foundation and NIHR Research Awards to recognise projects that actively involve patients, carers and service users. These awards help to encourage co-production in research and ensure that the voice of a broad range of lived experience is
taken into account when designing studies. The two projects recognised, the runners up EN-CAMHS and the winners NEON, are prime examples of when this is done well.
We have benefitted from the panoply of skills and talents of our corporate partner Deutsche Bank this year. The bank’s LGBTQ+ group, DB Pride, raised over £30,000 during their ‘Fundraiser on the Thames’ and we enjoyed engaging with other networks across the bank including the neurodiversity network. Over 1,300 people from around the world took part in a hackathon, to build a mobile phone app that can deliver an intervention for anxiety, developed by MQ Researcher Professor Colette Hirsch.
This year’s MQ Science Festival welcomed attendees from 37 countries around the world! Spanning five days, this multi-disciplinary event saw experts from Nigeria, Columbia, Malaysia and Pakistan join many, many others alongside host Professor Helen Fisher, to discuss the latest findings in mental health research and develop ideas for integrating our research into real public and policy change.
In total, through our research, partnerships and events, we have engaged with 7,718 volunteers and delegates from 41 countries in 2022.
We have grown our supporter base to the largest it has ever been, with a diversified income from trusts, foundations and more corporate partners that ever before, including our new partnership with The Lord Mayor’s Appeal which begins in 2023. You can learn more about our journey of growth and sustainability on page 8.
As we move into MQ’s tenth year, I’m very pleased to reflect on the wide variety of projects we have supported, the stakeholders we have engaged with, the careers we have boosted and the lives we have changed.
MQ Fellow, Dr Jessica Eccles, published her findings this year about the links between joint hypermobility and the emergence of anxiety and depression in adolescence, showing that there is a need for more targeted support for young people with hypermobility.
MQ’s newest trustee and presenter of the MQ OpenMind podcast, Professor Rory O’Connor, published the results from his MQ funded study which show a telephone intervention trial was successful at reducing repeated suicide attempts.
A study into COVID-induced cognitive decline, or ‘brain fog’, led by Oxford University researcher, Dr Maxime Taquet, and funded by MQ and the Wolfson Foundation, found evidence of the cause of brain fog and a possible treatment option that requires further study. You can read more about this on page 14.
I am very proud of all that MQ has been able to achieve in 2022. And in this, our tenth anniversary year, I hope that 2023, and indeed the next ten years, will be even more successful.
~~Dr Shahzad Malik Chair of MQ Mental Health Research~~
6
MQ 2022 ANNUAL REPORT
The statistics MQ’s achievements in 2022
We have developed a network of 124 early career researchers
with an interest in data science
No of papers published in 2022: 41
£988,330
of research grants delivered
research grants have been issued 45
The MQ Science Festival
engaged 1,998 people from 37 countries, either live or on catch up
The projects we are supporting have provided 38 new jobs
in addition to the principal researchers
Through our partnership with Deutsche Bank, we raised over £1 million!
The largest amount from a corporate partner in MQ’s history!
We have been named one of The Lord Mayor’s Appeal’s charity partners
for the next three years
$1.87million The MQ Foundation in the USA raised $1.87million in 2022
13%
We grew our digital subscribers, across all platforms, by 13%
7
MQ 2022 ANNUAL REPORT
Pathway to sustainability
A decade is a long time! A decade ago, One Direction were still together, England were winning the Ashes and Barrack Obama was being sworn in for his 2nd term. And yet, over the course of a decade, without consistent investment, energy and learning, we run the risk of seeing the opportunity for change pass us by.
A decade ago, a group of people passionate about Mental Health Research came together and, through a seed fund, generously set up by the Wellcome Trust, MQ made its first fledgling investment into mental health research.
Since then, MQ has invested in many groundbreaking research projects all around the world, helping to move the field of mental health science forward and bring the global research community together so that they can better collaborate.
These achievements in research have required boldness and courage to say that mental health research can be done in a better way, and that coproduction with people experiencing mental illness should be at the heart of the design. It was thanks to the initial seed funding supplied by Wellcome to launch the charity that we were able to take these, bold establishing steps. But we always knew that this seed funding was not intended to be relied on forever, and that to become truly self-sustaining, we
would need to be able to grow our supporter base, build relationships with the public and private sectors and diversify our income streams to become a truly independent voice for the changes needed in mental health, and to back this up with the best research from around the world.
~~The best time to plant a tree…~~
We’ve known for a long time that mental health is a societal challenge on an epic scale; that services have been historically underfunded and stigma has held back many from being able to get the help they needed. In amongst this, fantastic charities have been established to augment and fight for better services, providing helplines, schools-based support and campaigns to change how we think and speak about mental health.
However, if we want to truly fix the challenge we face, we know that research is a key component to the solution, and while research in mental health has been underfunded for years compared to research in physical health, the best time to start investing is right now to see the future transformed.
We’ve spent a decade crafting and honing the proof points of this message, working with partners and the public to help people understand that scaling existing services is important today, but without research the future will never change.
We ran high profile public awareness campaigns like the ‘We Swear’ campaign which included celebrities and familiar faces; we spoke with the largest
8
MQ 2022 ANNUAL REPORT
MQ has reached a new milestone. After tireless efforts from trustees, staff, leaders, donors and advocates, MQ has had its best ever fundraising year, commissioning more new research than ever before, and has done this without having to rely on the seed fund grant to achieve it.
It’s a success but it’s just the start of the next step of the journey!
foundations and donors to help educate them on the need for investment even if that meant not at MQ; and we worked with corporate partners to develop a clear understanding of their role in improving mental health.
It hasn’t always been easy and there have been times when momentum has stalled and changes in society, in our own staff team and understanding of the future vision, all had to be accounted for in moulding this fledgling organisation. However, over that decade the goal was always the same – find the best mental health research and drive it forward to transform lives!
I’m pleased to say that at the end of this decade,
~~A vision for the next decade~~
This first step, for many who started early in the journey, will feel like the moment a proud parent feels when they watch their child secure their first job, get into that university place they worked so hard for or make the first bold step of living in their own place!
It’s a success but it’s just the start of the next step of the journey! From here, MQ must redouble our efforts. This year, we want to look back and celebrate all we’ve achieved in a decade and use that as inspiration and learning for the next decade. A decade in which we want to see new breakthroughs in our understanding of mental health, new research commissioned across partners and disciplines, and ultimately see new ways to tackle the growing challenge of mental health globally.
Sustainability is setting the platform – now this sapling, planted a decade ago, that has borne its earliest fruit needs to blossom into a great and farreaching tree that will have impact for generations to come. With the launch of the MQ Foundation in the USA, perhaps we can even envisage an orchard in the future, seeing mental health research supported, launched and delivering for people wherever their mental health challenges meet them!
~~Lea Milligan CEO, MQ Mental Health Research~~
9
MQ 2022 ANNUAL REPORT
The MQ Science Council:
Global leadership in mental health science
In 2022, MQ appointed 10 new members to our Science Council, expanding it not just in size but also in skills and diversity.
The Council is made up of experts from across neuroscience, psychology, psychiatry and sociology, covering clinical and research expertise across all mental health disorders. These incredible global leaders donate their time for free, and their purpose is to plan, monitor and support the research that MQ funds. The science council is vital to ensure MQ's research is not only of the highest calibre but is also independently commissioned.
Professor Peter Jones MD, PHD, FMedSci
(Cambridge, England)
Chair of the Science Council Professor of Psychiatry at the University of Cambridge
NEW Professor Jehannine Austin PhD, FCAHS, CGC
(Canada, British Columbia)
Professor in Psychiatry & Medical Genetics at the University of British Columbia.
NEW Professor Hilary Blumberg
(USA, Connecticut) Professor of Psychiatric Neuroscience, Psychiatry, Radiology and Biomedical Imaging at Yale University
NEW Professor Kamaldeep Bhui CBE
(Oxford, England)
Professor of Psychiatry at the University of Oxford and Editor in Chief, British Journal of Psychiatry
Sir Philip Campbell PhD, DSc (UK, England) Editor-in-Chief, Springer Nature
NEW Professor Chan Lai Fong
(Malaysia)
Associate professor of psychiatry & consultant psychiatrist at the National University of Malaysia
NEW Dr Dixon Chibanda
(Zimbabwe)
Director of the African Mental Health Research Initiative (AMARI)
Professor Helen Fisher, PhD PGCAP
(London, England) Professor of Developmental Psychopathology, Kings College London
NEW Professor Stephani Hatch PhD, SFHEA
(London, England) Vice Dean for Culture, Diversity & Inclusion, Kings College London
Cynthia Joyce, MSc (USA, New York) Founding CEO of MQ
Professor Andrew M McIntosh MD, FRCPsych
(Edinburgh, Scotland) Chair of Biological Psychiatry, University of Edinburgh
Dr Helen Munn OBE, PhD (UK, England) Chair of External Scientific Advisory Board, NIHR
Professor Rory O’Connor PhD
(Glasgow, Scotland) Professor of Health Psychology, University of Glasgow
NEW Professor Henriette Raventós
(Costa Rica) Professor of Human Genetics, Universidad de Costa Rica
NEW Professor Karoline Kuchenbaecker
(UK, England) Professor of Genetic Epidemiology, UCL
NEW Dr Jessica Schleider (USA, New York) Assistant Professor of psychology, Stony Brook University
NEW Dr Daisy Singla (Canada, Toronto) Associate Professor, Department of Psychiatry, University of Toronto
Professor Carol Worthman, PhD
(USA, Atlanta) Samuel Candler Dobbs Professor of Anthropology Emerita
10
MQ 2022 ANNUAL REPORT
----- Start of picture text -----
11
----- End of picture text -----
Gone Too Soon
~~MQ~~ ’ ~~s newest thematic programme~~
People with mental illness and mental distress die too soon; their lives are scandalously short. This is due to the tragedy of suicide as well as a disproportionately high rate of physical health problems with low detection.
In response to this, MQ has launched a new thematic focus. Gone Too Soon is a funding and collaboration programme with one key aim: Trying to understand and prevent early mortality in those with mental illnesses and mental distress.
~~The Roadmap~~
In February and March 2022, two expert meetings were led by Professors Carol Worthman, from the Department of Anthropology at Emory College of Arts and Sciences and Rory O’Connor, Director of the Suicide Research laboratory at Glasgow University and one of MQ’s newest Trustees.
These meetings convened world-leading experts from many disciplines, including lived experience experts, to develop a roadmap for tackling premature deaths connected with mental illness and suicide. These meetings and subsequent report were held in partnership with the William Templeton Foundation for Young People’s Mental Health.
MQ 2022 ANNUAL REPORT
This road mapping exercise identified and explored the key priority issues, priority actionable solutions, and barriers that needed to be addressed.
In total 70 key issues and 12 common factors that contribute to suicide and physical health problems were identified. These include:
-
People with mental illness increasingly experience physical health problems including cancer, hypertension, cardiovascular disease and diabetes, to name a few, as well as health problems related to alcohol, tobacco, and substance use;
-
Physical and mental illnesses are also linked to higher rates of suicide;
-
Limited access to education, healthcare, housing and employment perpetuates stigma and social exclusion and increase risks of suicide as well as poor physical health;
-
People with poor mental health do not receive the same level of care for their physical health problems as the general population;
-
There is still compartmentalization of mental health vs physical health, with a lack of integration between the two when it comes to services.
18 possible solutions were laid out, including:
- Public health approaches that focus on prevention, including restricting access to lethal means of suicide, regulating tobacco, alcohol and media, promoting adequate nutrition, cash transfers and
better educating communities;
-
Community based interventions and support for families and peers to reduce stigma and social isolation;
-
Shift in the care approach towards integrated local health services; primary care services should have the capacity to treat mental and physical illnesses. This includes care providers training to improve screening and early intervention to reduce suicide, and to effectively treat physical illnesses for people with mental illness;
-
Partnering in action across countries and professionals, clinicians, community leaders, researchers, policy makers and lived experience experts who need to work together to tackle the global multifaceted risks and mobilise action.
However, several barriers were also identified including common barriers between both mental illnesses and suicide:
-
There is a lack of political will to create suitable policy, including lack of awareness of the issues by policy makers;
-
Lack of funding for health, social and safeguarding services and general dis-investment in mental health including research; and
-
Lack of interdisciplinary collaborations including social, biological, physiological and economic perspectives.
People with mental illness and mental distress pass away 10-20 years earlier than the general population
The Gone Too Soon project is only possible thanks to the generosity of our donors. Without their support, this vital research would not be possible and we would not be able to prevent the tragedy of lives lost too early due to mental illness.
The 2022 MQ Fellows (See the following
page) were made possible though a number of partnerships including with the American Foundation for Suicide prevention, JDRF, Garfield Weston, The Rosetrees Trust and the US based MQ Foundation.
12
MQ 2022 ANNUAL REPORT
Dr Suhas Ganesh from the Central Institute of Psychiatry Ranchi, in Kanke, India. Suhas will examine genetic and environmental predictors of treatment-emergent metabolic abnormalities in schizophrenia.
Dr Gareth Griffith from the University of Bristol, who will be working to improve study designs and participation in research of volunteers, to better understand why people die by suicide.
Dr Moritz Herle from King’s College London, who will be aiming to understand why people with eating disorders are at greater risk of suicide.
Dr Marisa Ellen Marraccini from the University of North Carolina, who will be building and testing a tailored virtual reality supplement to cognitive behavioural therapy to be provided during hospitalization after a suicide attempt.
Dr Leslie Carol Munoz Johnson from Emory University in Georgia, who will be adapting and testing an integrated care model for treatment of Type 1 diabetes and mental health co-morbidities.
Dr Massimilano Orri from McGill University in Canada will investigate the premature mortality by suicide and other causes of children with comorbid physical and mental disorders.
Dr Amy Ronaldson, also from Kings College London. Amy will seek to understand why the risk of death from infectious disease is higher in those with severe mental illness than in those without.
2022 MQ Fellows
We are very proud to be announcing seven new Fellowships, as part of the Gone Too Soon programme. This is MQ’s largest ever funding initiative, as we invest £2.2 million into these brand-new areas of research.
The MQ Fellowships are our flagship funding programme, supporting early career researchers in the most exciting and ground-breaking areas of mental health science. These Fellows went through a rigorous interview and vetting process. Their applications were reviewed by a diverse panel of global experts, including people with lived experience of mental illness.
13
MQ 2022 ANNUAL REPORT
What is brain fog?
Brain fog, or cognitive decline, is the feeling that thinking and memory is ‘foggy’ rather than clear.
It can cause short term memory loss, reduced or slowed thinking and can inhibit decision making.
Cognitive decline does happen naturally as we age but is also a symptom of brain injury or some illnesses.
14
MQ 2022 ANNUAL REPORT
Most people who recover from COVID-19 infection will not have any lingering symptoms. However, around 12% of people infected still have persistent symptoms for months, and even years afterwards. This is known as Long COVID. These symptoms can range from fatigue, dizziness, heart palpitations, depression and anxiety, and for around 8% of people, cognitive impairment or ‘brain fog’.
Brain fog is when someone’s memory, ability to concentrate or thinking process is slowed or reduced. This can impact a person’s ability to work, carry out everyday tasks and even care for themselves properly.
MQ has long worked with The Wolfson Foundation, an independent grant-making charity who specialise in education and research funding, so when they were looking for an opportunity to help researchers better understand the causes of Long-COVID and find solutions for those people impacted, they came to us.
Wolfson Chief Executive Paul Ramsbottom said “The long-term impact of COVID-19 infection is poorly understood. It is, however, sadly clear that the longterm health effects are profound - and being felt in societies across the globe. There is a danger that, as focus turns away from the pandemic, so less attention is paid to those continuing to suffer and the crucial ongoing need for research.”
NIHR Oxford Health BRC Senior Research Fellow, Maxime Taquet, from the University of Oxford and Oxford Health NHS Foundation Trust, wanted to investigate COVID induced ‘brain fog’ to better understand its causes.
Thanks to a grant from Wolfson, MQ was able to fund Maxime’s research which is already getting results.
Maxime and his team examined the long-term outcomes for over 1.25 million people who had been diagnosed with COVID-19. They found that there was an elevated risk of brain fog even two years after infection. Maxime then tested the hypothesis that the cause of this cognitive impairment might be to do with damage to small blood vessels in the brain, and has since found evidence to support this.
“These findings shed new light on the possible causes of brain fog and how it might be prevented in the future,” says Maxime.
His study identified that people who take phenytoin (an anti-convulsant medication which is known to block a particular molecule via which SARS-CoV-2 is thought to affect the brain) were at a 22-27% lower risk of post-COVID brain fog.
“We are definitely not suggesting that people should start taking phenytoin if they have COVID.” Says Maxime. “The goal of this study was to identify possible mechanisms, not possible treatments. The funding received by MQ and the Wolfson Foundation has been absolutely critical in delivering fast and detailed insights into the risk of brain fog after COVID-19 and its potential mechanisms. It has
facilitated collaborations across different departments within the University of Oxford as well as with other universities in the UK.”
Thanks to the collaboration between Maxime, the Wolfson Foundation and MQ, we may be one step closer to finding an effective intervention for people living with brain fog all around the world.
“Wolfson has a longstanding interest in the research and treatment of neurological conditions as well as an admiration for the work of MQ,” says Paul Ramsbottom. “We are very pleased to be supporting MQ and Maxime in this crucial work.”
~~Maxime Taque, University of Oxford~~
15
MQ 2022 ANNUAL REPORT
Financial Review and Strategic Report
Summary
Expenditure
MQ Mental Health Research achieved its best financial returns since its inception, seeing more partners and donors contribute to our work than ever before. The highlights of 2022 included our largest investment into the Fellows programme to date, securing new long-term partners such as the Lord Mayor of London Appeal and seeing our research into brain fog gain global press coverage.
Income
MQ Mental Health Research spent a total of £2.20m (2021: £1.59m) in charitable grants and programmes to help understand, treat and prevent mental ill-health. The consolidation of the UK team has yielded efficiencies and will impact future growth positively whilst ensuring fundraising expenditure £0.53m (2021: £0.48m) is kept at a competitive and appropriate proportion of expenditure. Recognising the uncertainty of 2023 and the ambitious research goals for 2021-26, the Trustees have retained a portion of the income to be spent on increasing operational delivery over the next year and supporting the launch of new research grants.
Whilst the challenges due to the COVID-19 pandemic lessened throughout the year, there were new challenges to face in raising funds. The war in Ukraine, the cost of living and energy crisis in the UK as well as significant instability in the financial markets in the last year, all had tangible and measurable impacts on our results and ability to mobilise funds. Despite this, the mitigation strategies and responsive hard work of the staff, ambassadors and Board saw the fantastic financial results we are able to report:
Overall income for the year increased by 89% to £3.54m (2021: £1.87m). Philanthropic income increased by 252% to £3.25m (2021: £0.92m) representing 92% of income (2021: 49%); of which £0.61m is from the US-based MQ Foundation. Other generated income decreased by 10% to £0.27m (2021: £0.30m). There was no draw down of seed funding from Wellcome (2021: £0.63m) setting a watershed moment in the journey to sustainability in realising a break-even position without reliance on this fund.
Reserve Policy
The Trustees review the reserves policy annually. In recognition of global financial uncertainty, the Trustees feel the current policy is adequate. The policy requires MQ Mental Health Research to hold reserves (unrestricted funds) to cover a minimum of six month’s expenses, based on the annual budget as agreed by the Board. This was set at £0.93m based on the 2023 budget excluding fixed assets.
As at 31 December 2022, the free reserves of the charity amounted to £0.96m. Restricted funds are not included in the reserves policy, as the Trustees have no discretion over how they are spent. If the Trustees choose to designate funds, these will not be included in the reserves policy, as they are held for a designated purpose. All grants’ awards are retained in designated or restricted funds to ensure the continuity of funding to researchers and institutions.
16
~~Financial Review and Strategic Report (Continued.)~~
MQ 2022 ANNUAL REPORT
Funds
range of segments and levels to reduce the potential impact of any sectorwide downturn.
At the end of 2022, total funds stood at £4.40m (2021 £3.58)
-
Restricted funds amounted to £1.52 (2021 £0.83) and are subject to conditions imposed by donors or implied by the nature of an appeal;
-
Designated funds of £1.92 (2021 £1.83) are held as awarded research grants; Unrestricted funds of £0.96 (2021 £0.92) comprise free reserves equivalent to 6 months based on 2023 budget.
Going concern
We have set out above a review of the financial performance during the financial year and our reserves position at the year-end. We have adequate financial resources and have the structures in place to manage the business risks. In addition, our budgeting and forecasting processes have taken into consideration the current economic climate and its potential impact on both our various sources of income and expenditure. We have a reasonable expectation that we have adequate resources and control mechanisms to continue in operational existence for the foreseeable future. Furthermore, we believe that there are no material uncertainties that may cast doubt on the charity’s ability to continue as a going concern.
Therefore, we continue to adopt the going concern basis of accounting in preparing the annual financial statements.
Risk management
The risks which face the charity are detailed in its consolidated risk register, which the Directors keep under active review. Headline Risks in 2022 include:
1. Uncertainty of the ongoing financial and social impact of global events
Mitigation – The board review stress testing of banking arrangements and have a diversified portfolio of risk. Fundraising efforts are focused on a
2. Risk of losing key personnel
Mitigation – Existing HR processes include detailed job descriptions with clear roles and responsibilities which are defined in a matrix structure. In addition, a list of accounts and passwords is securely stored and once business travel resumes, insurance for key staff is already in place. Temp and recruitment agencies have already been sourced in case of an urgent need for staff.
3. Donor pyramid is heavily weighted on large partnerships
Mitigation – Monitor fundraising channels closely and assess regularly. Document all trials, programmes for success/fail factors. Expanded the fundraising team with a focus on continued new partnership and business development opportunities to diversify the portfolio of income.
4. Income is outstripped by expenditure jeopardising the sustainability of the organisation resulting in lack of growth or closure.
Mitigation – Focused fundraising plans have been executed; scenario and sensitivity budgets developed; regular cashflow forecasting is undertaken. With an increase in longer-term funding partnerships, the risk of unsustainable fundraising decreased in medium term, but ongoing mitigation through unrestricted income generation is required for sustainability in 2025 and beyond.
The Trustees believe that appropriate policies to mitigate lower-level dayto-day risks have been adopted. They also believe that key financial systems are in place and appropriate internal controls are maintained for an organisation of the charity’s size and complexity. The overall financial and operational control environment is kept under regular review by the CEO and Director of Finance with regular reports provided to the Executive Team and Board.
17
~~Financial Review and Strategic Report (Continued.)~~
MQ 2022 ANNUAL REPORT
Future Plans
MQ is in the second year of its 5 year strategy that set out 4 strategic pillars:
Growing Talent Investing in Impact Challenging Inequality Engaging the Public
As we move into the second half of this strategy we are keen to continue to build on the platform we have created. We have set ambitious goals to continue to grow a cost effective fundraising plan that will allow us to deliver more research than ever before. Alongside the ongoing delivery of our existing grants portfolio participate platform the main activities scheduled for 2024 include:
Pre-Fellowship Programme – a new grant round focused on building the pipeline of early career researchers further up stream from our current Fellows programme
Inequalities – growth in our research focusing on mental health in low resource settings and how interventions and policy change can transform mental health
Public Involvement – continuing to develop our expertise in lived experience involvement in research with new products and tools to support the sector
Corporate Structure and Governance
MQ Mental Health Research, company number 07406055 and charity number 1139916 (England & Wales) and SC046075 (Scotland), is a charitable company limited by guarantee and not having a share capital. The charity is governed by its Memorandum and Articles of Association dated the 19th of January 2011 and it was incorporated on the 13th of October 2010. The Memorandum and Articles of Association were revised on the 12th of March 2019. Under the conditions of the guarantee, members’ liability is restricted to £1 each. The number of members in 2021 was 9 (2020 9).
MQ Mental Health Research is the owner of a registered trademark and, as such, through a license agreement, licenses The MQ Foundation, a 501c3 non-profit company registered in New York, USA.
Additional agreements define the operational and strategic links between the organisations, safeguarding the independence of both entities and their responsibilities for data protection, financial management, safeguarding and strategic operation.
New trustees receive an induction pack and a series of induction meetings with the Chair, CEO and executive team. The chair of the board is responsible of oversight of the development and training of the board and trustees are regularly updated with new resources from the Charity Commission, NCVO and AMRC by the Finance Director.
GALENOS – a three year programme to launch a new platform of living systematic reviews to set the course of research in anxiety, depression and psychosis
Dr Golam Khandaker conducted the first systematic review and meta-analysis that considered the peripheral blood cellular immunophenotype of depression.
18
~~Financial Review and Strategic Report (Continued.)~~
MQ 2022 ANNUAL REPORT
MQ Mental Health Research’s charitable objects
The Board has ongoing regard to the public benefit guidance published by the Charity Commission when reviewing the charity’s activities and future plans. MQ Mental Health Research continues to make a significant impact in funding and supporting ground-breaking research, convening experts through events and forums and supporting the publication of studies and reports. Regular monitoring and reporting of projects are carried out to ensure that MQ continues to deliver world-class research and is utilising funds in line with the wishes of donors in the UK, US and around the world.
Board and management roles
The MQ Mental Health Research Board of Trustees is legally responsible for the overall control of the charity and for ensuring that it is responsibly managed.
The Board’s principal roles are:
Approving the mission, strategies, policies and annual business plan; Appointing and overseeing the CEO;
Monitoring performance and risk management;
Reporting performance with integrity and transparency;
Safeguarding
MQ’s safeguarding arrangements are reviewed annually and the Trustees feel that policies in place represent a robust due diligence on those receiving grants, a strong framework to protect vulnerable donors and clear training and support for all staff engaging in frontline activities.
Setting the vision and maintaining high standards of stewardship and values; Ensuring compliance with UK law and Charity Commission regulations; Managing its governance processes;
Adding value by advising management; Representing the interests of MQ Mental Health Research’s stakeholders.
The Board delegates responsibility for operational management to the CEO (the Principal Officer), who is responsible for developing the organisation’s plans, policies and processes, following Board advice and approval. The Executive Team made up of the Heads of Finance; Research; Marketing, and Philanthropy & Partnerships, support the leadership of the organisation’s strategic growth. Salaries of key personnel are benchmarked with external research and agreed by the Board of Trustees.
Dr Ethel Mpungu from Uganda published the long-term findings of her MQ funded study this year, which found her intervention for people living with depression and HIV was successful in reducing symptoms of depression.
19
~~Financial Review and Strategic Report (Continued.)~~
MQ 2021 ANNUAL REPORT
Trustees’ responsibilities in relations to the financial statements
The trustees are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice.)
Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of the affairs of the charitable company and of its income and expenditure for that period. In preparing these financial statements, the trustees are required to:
select suitable accounting policies and then apply them consistently; observe the methods and principles in the Charities SORP;
make judgments and accounting estimates that are reasonable and prudent; state whether applicable Accounting Standards, including FRS 102, have
been followed, subject to any material departures disclosed and explained in the financial statements state whether a Statement of Recommended Practice (SORP) applies and has been followed, subject to any material departures which are explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in operation.
Disclosure of the information to Auditor
Each of the persons who are Trustees at the time when this Trustees’ report is approved has confirmed that:
-
so far as that Trustee is aware, there is no relevant audit information of which the charitable company’s auditors are unaware, and
-
that Trustee has taken all the steps that ought to have been taken as a Trustee in order to be aware of any information needed by the charitable company’s auditors in connection with preparing their report and to establish that the charitable company’s auditors are aware of that information.
Remuneration policy
MQ’s salaries are set within pay band structures at each grade, informed by external benchmarking, as necessary. The performance of key management personnel is monitored via regular one to one meetings with the CEO (and the CEO with the Chair), assessment against objectives and an annual appraisal process. Any salary awards for key management personnel must be approved by the board.
The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
MQ Fellow Dr Petra Vertes found that there are differences in the way male and female brains develop during adolescence that may be relevant to the risk of depression.
20
~~Financial Review and Strategic Report (Continued.)~~
MQ 2021 ANNUAL REPORT
Fundraising
MQ Mental Health Research complies with the Fundraising Standards Board Requirements and is registered with the Fundraising Regulator, only utilising agencies that are compliant with these standards. MQ does not solicit gifts by telephone or door to door acquisition methods, has received no complaints from any regulator and ensures that all donors receive only the communications they request.
Board meetings
The Board meets four times a year, with additional meetings as required. The Board has one subcommittee and one advisory body respectively:
-
Finance & Audit Committee – to independently review the audit results and report to the board;
-
Mental health Science Council – a global inter-disciplinary group of worldleading researchers that advises on the scientific strategy and work of the charity.
Board composition
The Board comprises independent, unremunerated, non-executive directors (trustees) who have a broad range of skills and experience including from scientific, clinical, financial, legal and strategic backgrounds. Recognising the international collaboration of charities, MQ Mental Health Research provides observers in the form of the UK Chair and the UK CEO to the MQ Foundation Board and, in return, receives two members from the MQ Foundation Board as full MQ Mental Health Research Trustees. As the Board continues to strengthen and expand, the Trustees are committed to the highest standards and encouraging applications from a diverse range of individuals.
Trustee recruitment, induction and training are overseen by working groups of the Board.
Board expenses
No fees or remuneration are paid for serving as a MQ Mental Health Research Board member. MQ Mental Health Research reimburses reasonable expenses incurred in the course of acting as a director. This includes travel and accommodation expenses required to attend meetings, training and orientation costs. Every effort is made to ensure costs are at a minimum.
These groups are established under formal terms of reference, which are reviewed annually. The groups include members with directly relevant experience. The Board does not delegate major decision-making powers to these groups and ratifies all recommendations.
Auditor
Moore Kingston Smith LLP were appointed as the charitable company’s auditor during the year and has expressed its willingness to continue in that capacity.
The Trustees annual report has been approved by the trustees on the 11th of April 2023 and signed on their behalf by:
Shahzad Malik Chairman
Helen Munn Trustee
21
MQ 2022 ANNUAL REPORT
Independent Auditor’s Report to the Members of MQ Transforming Mental Health
Opinion
Basis for opinion
We have audited the financial statements of MQ Transforming Mental Health (‘the company’) for the year ended 31 December 2022 which comprise the Statement of Financial Activities, the Summary Income and Expenditure Account, the Balance Sheet, the Cash Flow Statement and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice).
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
In our opinion the financial statements:
give a true and fair view of the state of the charitable company’s affairs as at 31 December 2022 and of its incoming resources and application of resources, including its income and expenditure, for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the Companies Act 2006, the Charities and Trustee Investment (Scotland) Act 2005 (as amended), regulations 6 and 8 of the Charities Accounts (Scotland) Regulations 2006 (as amended) and the Charities Act 2011.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.
22
~~Independent Auditor’s Report (Continued.)~~
MQ 2022 ANNUAL REPORT
Other information
The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
-
the information given in the strategic report and the trustees’ annual report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
-
the strategic report and the trustees’ annual report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the trustees’ annual report.
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
-
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
-
the financial statements are not in agreement with the accounting records and returns; or
-
certain disclosures of trustees’ remuneration specified by law are not made; or
-
we have not received all the information and explanations we require for our audit; or
-
the trustees were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies exemption in preparing the Trustees Annual Report and from preparing a Strategic Report.
Responsibilities of trustees
As explained more fully in the trustees’ responsibilities statement set out on page 19, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
23
~~Independent Auditor’s Report (Continued.)~~
MQ 2022 ANNUAL REPORT
In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.
Auditor’s responsibilities for the audit of the financial statements
We have been appointed as auditor under Section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005, the Companies Act 2006 and Section 151 of the Charities Act 2011 and report to you in accordance with regulations made under those Acts.
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also:
Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
-
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purposes of expressing an opinion on the effectiveness of the charitable company’s internal control.
-
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the trustees.
-
Conclude on the appropriateness of the trustees’ use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the charitable company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the charitable company to cease to continue as a going concern.
-
Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities,
24
~~Independent Auditor’s Report (Continued.)~~
MQ 2022 ANNUAL REPORT
outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.
The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the charitable company.
- Based on this understanding, we designed specific appropriate audit procedures to identify instances of non-compliance with laws and regulations. This included making enquiries of management and those charged with governance and obtaining additional corroborative evidence as required.
There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulations that are not closely related to events and transactions reflected in the financial statements. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.
Our approach was as follows:
We obtained an understanding of the legal and regulatory requirements applicable to the charitable company and considered that the most significant are the Companies Act 2006, the Charities Act 2011, the Charity SORP, the Charities and Trustee Investment (Scotland) Act 2005 (as amended), regulations 6 and 8 of the Charities Accounts (Scotland) Regulations 2006 (as amended) and UK financial reporting standards as issued by the Financial Reporting Council.
We obtained an understanding of how the charitable company complies with these requirements by discussions with management and those charged with governance.
We assessed the risk of material misstatement of the financial statements, including the risk of material misstatement due to fraud and how it might occur, by holding discussions with management and those charged with governance.
We inquired of management and those charged with governance as to any known instances of non-compliance or suspected non-compliance with laws and regulations.
Use of our report
This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006; and to the charity’s trustees, as a body, in accordance with Section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005, and in respect of the financial statements, in accordance with Chapter 3 of Part 8 of the Charities Act 2011. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to any party other than the charitable company and charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Date: 24 April 2023
Neil Finlayson (Senior Statutory Auditor)
for and on behalf of Moore Kingston Smith LLP, Statutory Auditor 9 Appold Street, London, EC2A 2AP.
25
MQ 2022 ANNUAL REPORT
Statement of financial activities (incorporating an income and expenditure account) For the year ended 31 December 2022
| Note | Unrestricted | Restricted | 2022 Total | 2021 Total | |
|---|---|---|---|---|---|
| £ | £ | £ | £ | ||
| Income from: | |||||
| Donations and legacies | 2 | 1,855,477 | 1,665,214 | 3,520,691 | 1,849,024 |
| Charitable activities | 3 | – | – | – | 12,181 |
| Investments | 4 | 21,831 | – | 21,831 | 11,455 |
| Total income | 1,877,308 | 1,665,214 | 3,542,522 | 1,872,660 | |
| Expenditure on: | |||||
| Raising funds | 5 | 530,616 | – | 530,616 | 475,016 |
| Charitable activities | |||||
| Scientifc research | 5 | 648,788 | 899,673 | 1,548,461 | 1,027,078 |
| Awareness raising and Advocacy | 5 | 573,712 | 73,098 | 646,810 | 565,107 |
| Total expenditure | 1,753,116 | 972,771 | 2,725,887 | 2,067,201 | |
| Net income for the year and net movement in funds | 7 | 124,192 | 692,443 | 816,635 | (194,541) |
| Reconciliation of funds: | |||||
| Total funds brought forward | 2,749,422 | 830,960 | 3,580,382 | 3,774,923 | |
| Total funds carried forward | 2,873,614 | 1,523,403 | 4,397,017 | 3,580,382 |
All of the above results are derived from continuing activities. There were no other recognised gains or losses other than those stated above. Movements in funds are disclosed in Note 16 to the financial statements. Full comparatives of the statement of financial activities are in Note 22.
26
MQ 2022 ANNUAL REPORT
Balance sheet
Company no. 07406055
As at 31 December 2022
| Balance sheet As at 31 December 2022 |
||
|---|---|---|
| Note | £ | 2022 £ £ |
| Fixed assets: Tangible assets Current assets: Debtors Cash at bank and in hand Liabilities: Creditors: amounts falling due within one year Net current assets 12 13 18 14 |
199,823 4,448,376 4,648,199 (266,011) |
14,829 14,829 4,382,188 375,903 3,410,113 3,786,016 (216,090) |
| Total net assets 15 |
4,397,017 | |
| The funds of the charity: Restricted funds Unrestricted funds (including designated funds) Designated funds General funds Total funds 16 16 16 |
1,523,403 1,917,665 955,949 |
4,397,017 830,960 1,833,003 916,419 |
| Total charity funds | 4,397,017 |
27
MQ 2022 ANNUAL REPORT
Statement of cash flows For the year ended 31 December 2022
| Note | £ | 2022 | £ | 2021 | |
|---|---|---|---|---|---|
| £ | £ | ||||
| Cash fows from operating activities | |||||
| Net cash provided by / (used in) operating activities | 17 | 1,027,117 | (408,378) | ||
| Cash fows from investing activities: Purchase of fxed assets |
(11,595) | (10,704) | |||
| Loss on Fixed asset disposal | 910 | – | |||
| Interest received | 21,831 | 11,455 | |||
| Net cash provided by / (used in) investing activities | 11,146 | 751 | |||
| Change in cash and cash equivalents in the year | 1,038,263 | (407,627) | |||
| Cash and cash equivalents at the beginning of the year | 3,410,113 | 3,817,740 | |||
| Cash and cash equivalents and net debt at the end of the year | 18 | 4,448,376 | 3,410,113 |
28
MQ 2022 ANNUAL REPORT
Notes to the financial statements For the year ended 31 December 2022
1 Accounting policies
a) Basis of preparation
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) - (Charities SORP FRS 102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy or note. The financial statements are prepared in sterling which is the functional currency of the charity, and rounded to the nearest £.
b) Public benefit entity
The charitable company meets the definition of a public benefit entity under FRS 102.
c) Going concern
The trustees consider that there are no material uncertainties about the charitable company’s ability to continue as a going concern for at least 12 months from the date of signing these financial statements. The trustees have considered possible events or conditions that might cast significant doubt on the ability of the charity to continue as a going concern, including the impact of the COVID-19 outbreak. The trustees have approved operational plans and expenditures based on income level and are confident of operating the charity within the parameters of our reserves policy. Also, the trustees review the annual budget during mid-year reforecast and reassess the reserve position. Accordingly, the trustees continue to adopt the going concern basis in the preparation of the financial statements.
d) Income
Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the income have been met, it is probable that the income will be received and that the amount can be measured reliably.
Income from government and other grants, whether ‘capital’ grants or ‘revenue’ grants, is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred.
For legacies, entitlement is taken as the earlier of the date on which either: the charity is aware that probate has been granted, the estate has been finalised and notification has been made by the executor(s) to the charity that a distribution will be made, or when a distribution is received from the estate. Receipt of a legacy, in whole or in part, is only considered probable when the amount can be measured reliably and the charity has been notified of the executor’s intention to make a distribution. Where legacies have been notified to the charity, or the charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy is a treated as a contingent asset and disclosed if material.
Income received in advance of the provision of a specified service is deferred until the criteria for income recognition are met.
e) Donations of gifts, services and facilities
Donated professional services and donated facilities are recognised as income when the charity has control over the item or received the service, any conditions associated with the donation have been met, the receipt of economic benefit from the use by the charity of the item is probable and that economic benefit can be measured reliably. In accordance with the Charities SORP (FRS 102), volunteer time is not recognised so refer to the trustees’ annual report for more information about their contribution.
29
MQ 2022 ANNUAL REPORT
1 Accounting policies (continued)
On receipt, donated gifts, professional services and donated facilities are recognised on the basis of the value of the gift to the charity which is the amount the charity would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.
- Other expenditure represents those items not falling into any other heading
Irrecoverable VAT is charged as a cost against the activity for which the expenditure was incurred.
i) Grants payable
f) Interest receivable
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the bank.
Grants payable are made to third parties in furtherance of the charity’s objects. Single or multi-year grants are accounted for when MQ upon annual review approve the milestones in the grant agreement are met. Contingent grant liabilities are disclosed when the charity has indicated a willingness to fund a project but the grant milestones have not yet been met (note 20).
g) Fund accounting
Restricted funds are to be used for specific purposes as laid down by the donor. Expenditure which meets these criteria is charged to the fund.
Unrestricted funds are donations and other incoming resources received or generated for the charitable purposes.
Designated funds are unrestricted funds earmarked by the trustees for particular purposes.
h) Expenditure and irrecoverable VAT
Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably. Expenditure is classified under the following activity headings:
-
Costs of raising funds relate to the costs incurred by the charitable company in inducing
-
third parties to make voluntary contributions to it, as well as the cost of any activities with a fundraising purpose
-
Expenditure on charitable activities includes the costs of grants to mental health research
-
organisations, advocacy activities and other educational and awareness raising activities undertaken to further the purposes of the charity and their associated support costs
When the intention to make a grant has been communicated to the recipient but there is uncertainty about either the timing of the grant or the amount of grant payable, the total grant commitment is set aside in a designated fund (note 20).
j) Allocation of support costs
Resources expended are allocated to the particular activity where the cost relates directly to that activity. However, the cost of overall direction and administration of each activity, comprising the salary and overhead costs of the central function, is apportioned on the following basis which are an estimate, based on staff time, of the amount attributable to each activity.
Where information about the aims, objectives and projects of the charity is provided to potential beneficiaries, the costs associated with this publicity are allocated to charitable expenditure.
Support and governance costs are re-allocated to each of the activities on the following basis which is an estimate, based on staff time, of the amount attributable to each activity.
| Scientifc research | 40% |
|---|---|
| Awareness raising and Advocacy | 25% |
| Cost of raising funds | 35% |
30
MQ 2022 ANNUAL REPORT
1 Accounting policies (continued)
Governance costs are the costs associated with the governance arrangements of the charity. These costs are associated with constitutional and statutory requirements and include any costs associated with the strategic management of the charity’s activities.
k) Operating leases
Rental charges are charged on a straight line basis over the term of the lease.
l) Tangible fixed assets
Items of equipment are capitalised where the purchase price exceeds £500. Depreciation costs are allocated to activities on the basis of the use of the related assets in those activities. Assets are reviewed for impairment if circumstances indicate their carrying value may exceed their net realisable value and value in use.
Depreciation is provided at rates calculated to write down the cost of each asset to its estimated residual value over its expected useful life. The depreciation rates in use are as follows:
| Leasehold Property | 5 years |
|---|---|
| Ofce Equipment | 3 years |
| Fixtures and Fittings | 5 years |
p) Creditors and provisions
Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
q) Estimates and Uncertainties
Key judgements that the charitable company has made which have a significant effect on the accounts include estimating the liability from multi-year grant commitments (see 1(i)).
The trustees do not consider that there are any sources of estimation uncertainty (other than grant commitments Note 20) at the reporting date that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next reporting period.
m) Debtors
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
r) Pensions
The charity operates a defined contribution pension scheme for employees. The assets of the scheme are held separately from those of the charity. The annual contributions payable are charged to the statement of financial activities.
n) Cash at bank and in hand
Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
o) Short term deposits
Short term deposits includes cash balances that are invested in accounts with a maturity date of between 3 and 12 months.
31
MQ 2022 ANNUAL REPORT
2 Income from donations and legacies
| 2022 | 2022 | 2022 | 2021 | 2021 | 2021 | |
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Unrestricted | Restricted | Total | |
| £ | £ | £ | £ | £ | £ | |
| Gifts | ||||||
| Individual Giving | 198,577 | 2,498 | 201,075 | 196,262 | 2,890 | 199,152 |
| Wellcome Trust* | – | 42,889 | 42,889 | 630,412 | 56,880 | 687,292 |
| Philanthropy and Partnerships | 1,656,900 | 1,597,093 | 3,253,993 | 515,189 | 408,266 | 923,455 |
| Co-Funding | – | 22,734 | 22,734 | – | 37,125 | 37,125 |
| Legacies | – | – | – | 2,000 | – | 2,000 |
| 1,855,477 | 1,665,214 | 3,520,691 | 1,343,863 | 505,161 | 1,849,024 |
*Under the Wellcome Trust’s Grant Letter of 16th January 2012, at the balance sheet date, the charity had drawn down £21m. The company can in due course (and subject to compliance with the requirements set out in the grant letter) drawdown in aggregate, a further £1.9m (2020: £2.4m).
3 Income from charitable activities
| 2022 | 2022 | 2022 | 2021 | 2021 | 2021 | |
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Unrestricted | Restricted | Total | |
| £ | £ | £ | £ | £ | £ | |
| Contributions towards scientifc | ||||||
| meetings | – | – | – | 12,181 | – | 12,181 |
32
MQ 2022 ANNUAL REPORT
4 Income from investments
| 4Income from | investments | |||||
|---|---|---|---|---|---|---|
| 2022 | 2022 | 2022 | 2021 | 2021 | 2021 | |
| Unrestricted | Restricted | Total | Unrestricted | Restricted | Total | |
| £ | £ | £ | £ | £ | £ | |
| Bank interest received | 21,831 | – | 21,831 | 11,455 | – | 11,455 |
| 21,831 | – | 21,831 | 11,455 | – | 11,455 |
5 Analysis of expenditure
| Cost of raising funds |
Scientifc research £ Awareness raising and Advocacy £ ~~Charitable activities~~ |
Scientifc research £ Awareness raising and Advocacy £ ~~Charitable activities~~ |
Governance costs £ |
Support costs £ |
2022 Total £ |
|
|---|---|---|---|---|---|---|
| Staf costs (Note 8) Grant-making (Note 6) Other direct costs Ofce costs Audit Bank charges Foreign exchange (gains) and losses Meetings Legal fees Support costs Governance costs |
178,799 – 198,781 348 – 25 – 21,320 – 399,273 104,734 26,609 |
300,068 988,330 102,228 – – 620 – 7,109 – 1,398,355 119,696 30,410 |
225,595 – 326,977 223 – 35 – 163 – 552,993 74,810 19,007 |
24,210 – 6,119 214 22,934 29 – 10,250 12,270 76,026 – (76,026) |
121,050 – 22,468 165,201 – 1,245 (23,779) 12,609 446 299,240 (299,240) – |
849,722 988,330 656,573 165,986 22,934 1,954 (23,779) 51,451 12,716 |
| 2,725,887 – – |
||||||
| Total expenditure 2022 | 530,616 | 1,548,461 | 646,810 | – | – | 2,725,887 |
Of the total expenditure, £1,928,514 was unrestricted (2021: £1,928,514) and £138,687 was restricted (2021: £138,687).
33
MQ 2022 ANNUAL REPORT
5 Analysis of expenditure (continued)
| Cost of raising funds |
Scientifc research £ Awareness raising and Advocacy £ ~~Charitable activities~~ |
Scientifc research £ Awareness raising and Advocacy £ ~~Charitable activities~~ |
Governance costs £ |
Support costs £ |
2021 Total £ |
|
|---|---|---|---|---|---|---|
| Staf costs (Note 8) Grant-making (Note 6) Other direct costs Ofce costs Audit Bank charges Foreign exchange (gains) and losses Meetings Legal fees Support costs Governance costs |
142,547 – 216,076 170 – 51 – 1,865 – 360,709 98,631 15,676 |
259,532 547,766 66,426 31 – 34 – 22,652 – 896,441 112,722 17,915 |
178,024 – 305,344 6 – 85 – – – 483,459 70,451 11,197 |
21,156 – 134 – 16,770 3 – 6,275 450 44,788 – (44,788) |
105,782 – 21,592 150,033 – 1,106 (1,796) 5,087 – 281,804 (281,804) – |
707,041 547,766 609,572 150,240 16,770 1,279 (1,796) 35,879 450 |
| 2,067,201 – – |
||||||
| Total expenditure 2021 | 475,016 | 1,027,078 | 565,107 | – | – | 2,067,201 |
6 Grant making (Grants to institutions)
| 2022 | 2021 | |
|---|---|---|
| £ | £ | |
| Cost | ||
| Fellows Programme | 275,692 | 178,502 |
| PsyIMPACT | – | 44,793 |
| Data Science | – | 41,908 |
| Brighter Futures | 370,638 | 282,563 |
| At the end of the year | 646,330 | 547,766 |
34
MQ 2022 ANNUAL REPORT
6 Grant making (Grants to institutions) (continued)
The Fellows programme supports the brightest and best early career scientists who are asking challenging questions that will contribute to transformative advances in mental health.
The PsyIMPACT programme supports innovative research to develop and test psychological treatments, getting people the right treatments faster.
The Data Science programme awards grants to help realise the huge potential in the near term to harness data science to drive forward research.
The aims of MQ’s Brighter Futures programme stem from the fundamental belief that research can change the trajectory of mental illness in young people, tackling the life-long impacts of many conditions and working towards a world where mental illness may one day be made preventable.
7 Net income for the year
This is stated after charging / (crediting):
| This is stated after charging / (crediting): | ||
|---|---|---|
| 2022 | 2021 | |
| £ | £ | |
| Depreciation | 6,311 | 3,648 |
| Property lease rentals | 114,000 | – |
| Auditors’ remuneration (excluding VAT) | 19,112 | – |
| Foreign exchange (gains)/ losses | (23,779) | (1,796) |
35
MQ 2022 ANNUAL REPORT
8 Analysis of staff costs, trustee remuneration and expenses, and the cost of key management personnel
Staff costs were as follows:
| Staf costs were as follows: | ||
|---|---|---|
| 2022 | 2021 | |
| £ | £ | |
| Salaries and wages | 736,358 | 617,367 |
| Social security costs | 79,358 | 61,876 |
| Employer’s contribution to defned contribution pension schemes | 34,006 | 27,798 |
| 849,722 | 707,041 |
There is no redundancies in 2022 (2021: £15,000).
The following number of employees received employee benefits (excluding employer pension costs) during the year between:
| 2022 | 2021 | |
|---|---|---|
| No. | No. | |
| £60,000 – £69,999 | 1 | 1 |
| £70,000 – £79,999 | 1 | 1 |
| £100,000 – £109,999 | – | – |
| £110,000 – £119,999 | 1 | 1 |
The pension contributions paid to higher employees amounted to £12,469 (2021: £8,310).
The total employee benefits (including employers’ NI and pension contributions) of the key management personnel (CEO, Director of Finance, Head of Philanthropy & Partnerships and Head of Marketing) were £363,221 (2021: £391,256).
The charity trustees were not paid or received any other benefits from employment with the charity in the year (2021: £nil). No charity trustee received payment for professional or other services supplied to the charity (2021: £nil).
Trustees’ expenses represents the payment or reimbursement of travel and subsistence costs totalling £10,533 (2021: £6,862) incurred by 10 (2021: 9) members relating to attendance at meetings of the trustees.
36
MQ 2022 ANNUAL REPORT
9 Staff numbers
The average number of employees (head count based on number of staff employed) during the year was as follows:
| 2022 | 2021 | |
|---|---|---|
| No. | No. | |
| Raising funds | 5 | 3 |
| Scientifc research (Including one Part time staf) | 3 | 4 |
| Awareness raising and advocacy | 5 | 3 |
| Support (Including one Part time staf) | 3 | 4 |
| Governance | – | – |
| 16 | 14 |
10 Related party transactions
Aggregate donations from trustees were £25,360 (2021: £147,066).
MQ works closely with The MQ Foundation, a US-based s501c3 public charity founded in 2018, whose mission and priorities are closely aligned with those of MQ. MQ has licensed the MQ brand to the MQ Foundation to foster synergy and efficiency between the two organisations. The MQ Foundation board remains an independent body with discretion on how to allocate funds toward its mission. Two of the MQ Foundation board members John A Herrmann and Michael J Horvitz sit on the Board of MQ. However, neither charity exerts control over the other. In 2022 MQ Foundation provided grants totalling $625,000 to MQ.
11 Taxation
The charitable company is exempt from corporation tax as all its income is charitable and is applied for charitable purposes.
37
MQ 2022 ANNUAL REPORT
12 Tangible fixed assets
| Fixtures and fttings |
Ofce equipment £ |
Total £ |
|
|---|---|---|---|
| £ | |||
| Cost | |||
| At the start of the year | 2,761 | 65,420 | 68,181 |
| Additions in year | – | 11,595 | 11,595 |
| Disposals in year | – | (31,656) | (31,656) |
| At the end of the year | 2,761 | 45,359 | 48,120 |
| Depreciation | |||
| At the start of the year | 2,517 | 55,208 | 57,725 |
| Charge for the year | 193 | 6,118 | 6,311 |
| Eliminated on disposal | – | (30,746) | (30,746) |
| At the end of the year | 2,710 | 30,580 | 33,290 |
| Net book value | |||
| At the end of the year | 51 | 14,778 | 14,829 |
| At the start of the year | 244 | 10,212 | 10,456 |
38
MQ 2022 ANNUAL REPORT
13 Debtors
| 13Debtors | ||
|---|---|---|
| 2022 | 2021 | |
| £ | £ | |
| Trade debtors | – | – |
| Other debtors | 57,016 | 57,000 |
| Accrued Income | 81,864 | 255,767 |
| Prepayments | 60,943 | 63,136 |
| 199,823 | 375,903 |
14 Creditors: amounts falling due within one year
| 2022 | 2021 | |
|---|---|---|
| £ | £ | |
| Trade creditors | 8,951 | 7,020 |
| Other creditors | 5,154 | 2,964 |
| Deferred Income | 150,000 | 160,000 |
| Grant Accruals | 82,724 | 31,946 |
| Other Accruals | 19,182 | 14,160 |
| 266,011 | 216,090 |
39
MQ 2022 ANNUAL REPORT
15 Analysis of net assets between funds
| a) At 31 December 2022 | Restricted | Unrestricted | Total funds |
|---|---|---|---|
| £ | £ | £ | |
| Tangible fxed assets | – | 14,829 | 14,829 |
| Current assets | 1,523,403 | 3,124,796 | 4,648,199 |
| Current liabilities | – | (266,011) | (266,011) |
| Net assets at the end of the year | 1,523,403 | 2,873,614 | 4,397,017 |
| b) At 31 December 2021 | Restricted | Unrestricted | Total funds |
|---|---|---|---|
| £ | £ | £ | |
| Tangible fxed assets | – | 10,456 | 10,456 |
| Current assets | 830,960 | 2,955,056 | 3,786,016 |
| Current liabilities | – | (216,090) | (216,090) |
| Net assets at the end of the year | 830,960 | 2,749,422 | 3,580,382 |
40
MQ 2022 ANNUAL REPORT
16 Movements in funds
| a) Year ended 31 December 2022 | At the start of | Incoming | Outgoing | Transfer | At the end of the |
|---|---|---|---|---|---|
| the year | resources & gains | resources & losses | £ | year | |
| £ | £ | £ | £ | ||
| Restricted Funds | |||||
| Brighter Futures IDEA | 266,480 | 124,789 | (93,940) | – | 297,329 |
| Fellows | 548,882 | 874,134 | (254,704) | – | 1,168,312 |
| Research Activities | – | 608,791 | (551,029) | – | 57,762 |
| ENIGMA Book | 15,598 | 57,500 | (73,098) | – | – |
| Total restricted funds | 830,960 | 1,665,214 | (972,771) | – | 1,523,403 |
| Unrestricted funds: | |||||
| Designated funds: | |||||
| Grant commitments | 1,833,003 | (694,453) | 779,115 | 1,917,665 | |
| Total designated funds | 1,833,003 | – | (694,453) | 779,115 | 1,917,665 |
| General funds | 916,419 | 1,877,308 | (1,058,663) | (779,115) | 955,949 |
| Total unrestricted funds | 2,749,422 | 1,877,308 | (1,753,116) | – | 2,873,614 |
| Total funds | 3,580,382 | 3,542,522 | (2,725,887) | – | 4,397,017 |
41
MQ 2022 ANNUAL REPORT
16 Movements in funds (continued)
| a) Year ended 31 December 2021 | At the start of | Incoming | Outgoing | Transfer | At the end of the |
|---|---|---|---|---|---|
| the year | resources & gains | resources & losses | £ | year | |
| £ | £ | £ | £ | ||
| Restricted Funds | |||||
| Brighter Futures ADP | – | 240 | (240) | – | – |
| Brighter Futures Hopes | 1,000 | – | (1,000) | – | – |
| Brighter Futures IDEA | 0 | 266,480 | – | – | 266,480 |
| Fellows | 359,098 | 151,561 | (66,165) | 104,388 | 548,882 |
| Mental Health Science Meeting | 56,880 | (56,880) | – | – | |
| Howell Jadwiga Fund | 104,388 | (104,388) | – | ||
| ENIGMA Book | – | 30,000 | (14,402) | – | 15,598 |
| Total restricted funds | 464,486 | 505,161 | (138,687) | – | 830,960 |
| Unrestricted funds: | |||||
| Designated funds: | |||||
| Grant commitments | 2,082,127 | – | (549,086) | 299,962 | 1,833,003 |
| Total designated funds | 2,082,127 | – | (549,086) | 299,962 | 1,833,003 |
| General funds | 1,228,310 | 1,367,499 | (1,379,428) | (299,962) | 916,419 |
| Total unrestricted funds | 3,310,437 | 1,367,499 | (1,928,514) | – | 2,749,422 |
| Total funds | 3,774,923 | 1,872,660 | (2,067,201) | – | 3,580,382 |
42
MQ 2022 ANNUAL REPORT
16 Movements in funds (continued)
Purposes of restricted funds
| Brighter Futures IDEA | This fund contributes money toward the IDEA of the Brighter Futures project |
|---|---|
| Brighter Futures ADP | This fund contributes money toward the Adolescent Data Platform workstream of the Brighter Futures project |
| Brighter Futures HOPES | This fund contributes money toward the HOPES workstream of the Brighter Futures project |
| Data Science | This fund is used to help fund our data science programme |
| Fellows | This fund helps to pay for new and existing MQ Fellows |
| PsyImpact | This fund helps to pay for our PsyImpact programme |
| Mental Health Science Meeting | It is an annual event which bring together scientists, mental health stakeholders and policy-makers from across the UK and beyond. |
| Research Activities | This is combined of research activities which is delivered by research team. |
| Howell Jadwiga Fund | This fund helps to pay for our Borderline Personality Disorder project which has been awarded in 2020. Therefore the funds has |
| been transferred to Fellows fund. | |
| ENIGMA Book | Co-produced with our corporate partner Enigma Holdings the Enigma book uses the personal stories of celebrities and other |
| people with loved experience to explain diferent mental health conditions and the latest research around them. |
Purposes of designated funds
Grant commitments represent amounts awarded in relation to our Fellows, Data Science, Bright Futures and PsyIMPACT programmes payable in future years but where there is uncertainty of the timing of the grant payment as it is dependent on milestones being achieved.
43
MQ 2022 ANNUAL REPORT
17 Reconciliation of net income / (expenditure) to net cash flow from operating activities
from operating activities |
||
|---|---|---|
| 2022 | 2021 | |
| £ | £ | |
| Net income for the reporting period (as per the statement of fnancial activities) | 816,635 | (194,541) |
| Depreciation charges | 6,311 | 3,648 |
| Interest Received | (21,831) | (11,455) |
| Decrease/(increase) in debtors | 176,080 | (208,967) |
| (Decrease) / Increase in creditors | 49,922 | 2,937 |
| Net cash provided by / (used in) operating activities | 1,027,117 | (408,378) |
18 Analysis of cash and cash equivalents and changes in net debt
| At 1 January 2022 | Cash fows | At 31 December | |
|---|---|---|---|
| £ | £ | 2022 | |
| £ | |||
| Cash at bank and in hand | 3,410,113 | 1,038,263 | 4,448,376 |
| Overdraft, Loan and Finance Lease | – | – | – |
| Total cash and cash equivalents | 3,410,113 | 1,038,263 | 4,448,376 |
44
MQ 2022 ANNUAL REPORT
19a Commitments
The charity’s total future minimum lease payments under non-cancellable leases is as follows for each of the following periods
| Land & Buildings | Other | Land & Buildings | Other | |
|---|---|---|---|---|
| 2022 | 2022 | 2021 | 2021 | |
| £ | £ | £ | £ | |
| Within one year | 136,800 | 698 | 78,000 | 377 |
| Two to fve years Over fve years |
159,600 – |
407 – |
202,800 – |
– – |
| Total | 296,400 | 1,105 | 280,800 | 377 |
19b Operating Lease Income
Future payments receivable under these non–cancellable operating leases for each of the following periods following the balance sheet date are:
| 2022 | 2021 | |
|---|---|---|
| £ | £ | |
| Within one year | 50,160 | 50,160 |
| Two to fve years | 4,560 | 4,560 |
| Total | 54,720 | 54,720 |
45
MQ 2022 ANNUAL REPORT
20 Grant commitments
At 31 December 2022, the charity has committed to future expenditure amounting to £1,833,003 (2021 – £1,833,003) in relation to its Fellows, Data Science, Brighter Futures and PsyIMPACT programmes. The movements on these commitments are as below.
| 2022 | 2021 | |
|---|---|---|
| £ | £ | |
| Balance at the start of the year | 1,833,003 | 2,082,127 |
| New grants committed to | 779,115 | 299,962 |
| Exchange Rate diferences/(write back) | (48,123) | (1,320) |
| Expended in the year | (646,330) | (547,766) |
| Balance at the end of the year | 1,917,665 | 1,833,003 |
| These commitments are expected to be payable as follows | ||
| In one year | 868,670 | 886,965 |
| In two to fve years | 1,048,995 | 946,038 |
| Total | 1,917,665 | 1,833,003 |
The grant commitments are not fully recognised in the year they are committed, as they are subject to annual progress review before further instalments are released. The amounts accounted for in the year are those MQ deem the milestones in the grant agreement have been met.
21 Legal status of the charity
The charity is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up is limited to £1.
46
MQ 2022 ANNUAL REPORT
22 (incorporating an income and expenditure account) Statement of financial activities
| Note | Unrestricted | Restricted | 2021 Total | |
|---|---|---|---|---|
| £ | £ | £ | ||
| Income from: | ||||
| Donations and legacies | 2 | 1,343,863 | 505,161 | 1,849,024 |
| Charitable activities | 3 | 12,181 | – | 12,181 |
| Investments | 4 | 11,455 | – | 11,455 |
| – | – | – | ||
| Total income | 1,367,499 | 505,161 | 1,872,660 | |
| Expenditure on: | ||||
| Raising funds | 5 | 475,016 | – | 475,016 |
| Charitable activities | ||||
| Scientifc research | 5 | 888,391 | 138,687 | 1,027,078 |
| Awareness raising and Advocacy | 5 | 565,107 | – | 565,107 |
| Total expenditure | 1,928,514 | 138,687 | 2,067,201 | |
| Net income for the year and net movement in funds | 7 | (561,015) | 366,474 | (194,541) |
| Reconciliation of funds: | ||||
| Total funds brought forward | 3,310,437 | 464,486 | 3,774,923 | |
| Total funds carried forward | 2,749,422 | 830,960 | 3,580,382 |
All of the above results are derived from continuing activities. There were no other recognised gains or losses other than those stated above. Movements in funds are disclosed in Note 16 to the financial statements.
47
Registered charity in England / Wales: 1139916 & Scotland: SC046075 Company number: 7406055